A randomized clinical trial of cognitive-behavioral group therapy and sertraline in the treatment of obsessive-compulsive disorder.

@article{Sousa2006ARC,
  title={A randomized clinical trial of cognitive-behavioral group therapy and sertraline in the treatment of obsessive-compulsive disorder.},
  author={Marcelo Basso de Sousa and Luciano Rassier Isolan and Renata R Oliveira and Gisele Gus Manfro and Aristides Volpato Cordioli},
  journal={The Journal of clinical psychiatry},
  year={2006},
  volume={67 7},
  pages={
          1133-9
        }
}
BACKGROUND Cognitive-behavioral group therapy (CBGT) and serotonin reuptake inhibitors have proven efficacy in reducing symptoms of obsessive-compulsive disorder (OCD). There is no consensus about which of these forms of treatment is more effective. This study was conducted to evaluate the efficacy of CBGT as compared to that of sertraline in reducing OCD symptoms. METHOD Fifty-six outpatients with an OCD diagnosis, according to DSM-IV criteria, participated in the randomized clinical trial… 

Figures and Tables from this paper

Cognitive-Behavioral Group Therapy versus Sertraline for Obsessive-Compulsive Disorder: Five-Year Follow-Up
TLDR
Whether the reduction in severity of OCD symptoms obtained with 12-weekly sessions of CBGT or with sertraline during the same period, in a randomized clinical trial, would be sustained over a 5-year period is investigated as well as to compare the differences between the 2 treatments in the long term.
Cognitive-coping therapy for obsessive-compulsive disorder: a randomized controlled trial.
A promising randomized trial of a new therapy for obsessive–compulsive disorder
TLDR
The preliminary data suggest that PCCT is a more efficacious psychotherapy for OCD patients than pharmacotherapy or PCBT, and this approach in a larger sample size.
[Cognitive-behavior therapy for obsessive-compulsive disorder: a systematic review of the last decade].
TLDR
Cognitive and behavioral therapies have shown to be highly effective psychotherapeutic approaches for the treatment of obsessive-compulsive disorder, and exposure and response prevention associated with cognitive therapy may result in significant benefits to patients with predominant obsessive thoughts.
Acceptance and Commitment Therapy, Selective Serotonin Reuptake Inhibitors and Their Combination in the Improvement of Obsessive-Compulsive Symptoms and Experiential Avoidance in Patients With Obsessive-Compulsive Disorder
TLDR
It appears that adding SSRIs to ACT does not increase the effectiveness of ACT in the treatment of adults with OCD in the short-term, and patients treated with ACT and combined treatment experienced a significantly greater improvement in obsessive-compulsive symptoms and experiential avoidance at post-treatment.
Full remission and relapse of obsessive-compulsive symptoms after cognitive-behavioral group therapy: a two-year follow-up.
TLDR
The findings underscore the importance of attaining full remission of obsessive-compulsive symptoms during treatment and the need for new therapeutic strategies to achieve this.
The Metacognitive Training for obsessive-compulsive disorder: A pilot study
More than 50% of patients with obsessive-compulsive disorder (OCD) do not receive first-line psychological treatment such as cognitive-behavioral therapy with exposure and response prevention. To
...
...

References

SHOWING 1-10 OF 46 REFERENCES
A Randomized Controlled Trial of Japanese Patients with Obsessive-Compulsive Disorder – Effectiveness of Behavior Therapy and Fluvoxamine
TLDR
Behavior therapy improved the condition of OCD patients more than fluvoxamine, and patients with lower baseline total Y-BOCS, past history of a major depressive episode and absence of cleaning compulsion improved more with fluv oxamine.
Cognitive-Behavioral Group Therapy in Obsessive-Compulsive Disorder: A Randomized Clinical Trial
TLDR
The results suggest that CBGT is effective in reducing the intensity of OCD symptoms and of overvalued ideas, and that it improves the OCD patient’s quality of life in a short period of time.
High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial.
TLDR
Greater symptom improvement was seen in the high-dose sertraline group compared to the 200-mg/day dose group during continuation treatment, and Administration of higher than labeled doses of selective serotonin reuptake inhibitors may be a treatment option for certain OCD patients who fail to respond to standard acute treatment.
Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder.
TLDR
Results of the Y-BOCS total score, the NIMH score, and the global severity and improvement scores demonstrated a statistically significant superiority of sertraline compared with placebo.
Efficacy of sertraline in the long-term treatment of obsessive-compulsive disorder.
TLDR
During the study's last 28 weeks, sertraline demonstrated greater efficacy than placebo in preventing dropout due to relapse or insufficient clinical response and acute exacerbation of OCD symptoms.
A 1 year double‐blind placebo‐controlled fixed dose study of sertraline in the treatment of obsessive‐compulsive disorder
TLDR
Results support the safety, efficacy and tolerability of daily doses of 50–200 mg of sertraline in the long-term treatment of patients with OCD.
Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder.
TLDR
Results support the safety and efficacy of daily dosages of 50, 100, and 200 mg of sertraline in the short-term treatment of patients with OCD.
A Comparison of Behavioral Group Therapy and Individual Behavior Therapy in Treating Obsessive-Compulsive Disorder
TLDR
Both individual and group interventions proved to be equally effective at reducing distress caused by OCD symptoms, general depression, and anxiety by the end of treatment, although patients in the individual behavior therapy condition demonstrated faster reductions in OCD symptom severity.
A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder.
TLDR
Over 12 weeks, fluvoxamine CR treatment was associated with a statistically significant and clinically relevant reduction in OCD severity and was found to be safe and well tolerated.
...
...